Syros Pharma is a cutting-edge pharmaceutical brand that specializes in gene control for the development of innovative medicines. Their gene control platform serves as the foundation for their clinical stage pipeline and has allowed them to identify targets and biomarkers for drug development. Through the analysis of regulatory regions in the genome, they have identified super-enhancers, which are crucial in controlling the expression of genes in specific cell types and diseases.

By comparing healthy and diseased cells, they have pinpointed disease-causing alterations and identified drug targets and patient subsets for therapeutic benefits. The brand combines their expertise in regulatory genomics and disease biology to create profound and durable treatments for diseases that have previously eluded other approaches. Additionally, Syros Pharma excels in small molecule chemistry, allowing them to selectively modulate transcription factors and other regulatory proteins to control gene expression.

They also actively seek partnerships to maximize value for their partners and continue their groundbreaking research. Discover more about their platform and programs through their publications and abstracts